Sun Pharma to delist Ranbaxy on completion of $4 bn merger
The merger has fortified Sun Pharma's position as the world's fifth largest speciality generic pharmaceutical firm.
Mar 25, 2015, 14:06 PM IST
The merger has fortified Sun Pharma's position as the world's fifth largest speciality generic pharmaceutical firm.
Mar 25, 2015, 14:06 PM IST